Evaluating a device to help patients with motor disabilities control external equipment
Official title: A Prospective Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability
Run by Neuracle Medical Technology(Shanghai) Co.,Ltd. · NCT05920174 · Data updated 2026-11-12
This study is testing a new device that helps people with motor disabilities, like tetraplegia, control things like wheelchairs and robotic arms using their brain signals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 9 (estimated) |
| Sponsor | Neuracle Medical Technology(Shanghai) Co.,Ltd. Industry-sponsored |
| Locations | 4 sites (Beijing, Beijing Municipality and 3 other locations) |
| Status | Recruiting |
| Started | October 17, 2023 |
| Main results expected | December 2024 |
| Study ends | December 2025 |
| Registry record updated | December 5, 2024 |
| Trial ID | NCT05920174 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 80 with stable complete or incomplete quadriplegia due to spinal cord injury, brain stem stroke, or motor neuron disorders.
✕Probably not a fit
Patients with progressive neurological diseases or significant visual impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to assess the safety and efficacy of an implantable neural acquisitor and stimulator system designed for patients with motor disabilities, specifically those with tetraplegia. Utilizing brain-computer interface technology, the system allows patients to control external devices such as wheelchairs and robotic arms using their brain signals. The study will include patients diagnosed with complete or incomplete quadriplegia due to various neurological conditions, ensuring they have a functional brain motor-related cortex. Participants will be monitored for their ability to use the device effectively and safely over the course of the trial.
Why it matters
Potential benefit: If successful, this technology could significantly enhance the quality of life for patients with motor disabilities by providing them greater independence and control over their environment.
How similar studies have gone: While the approach of using brain-computer interfaces is gaining traction, this specific application in motor disabilities is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged between 18 and 80 years of age; 2. Complete or incomplete quadriplegia due to spinal cord injury, brain stem stroke, amyotrophic lateral sclerosis and other motor neuron disorders; 3. After the neurological assessment, the brain motor-related cortex is functional, and there is no obvious organic disease or functional disease; 4. The above diseases have been diagnosed for at least 12 months and stable for at least 6 months after standard treatment; 5. The patient had normal cognitive function, good compliance and volunteered to participate in the clinical trial. Exclusion Criteria: 1. Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses; 2. Combined with progressive neurological disease; 3. Combined with surgical contraindications identified by surgeons and anesthesiologists; 4. Participating in other clinical trials; 5. Other conditions deemed inappropriate by investigators and medical staff.
Where it's running
-
Xuanwu Hospital,Capital Medical University
Beijing, Beijing Municipality, China Recruiting -
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting -
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China Recruiting -
Chinese PLA General Hospital
Beijing, Beijing Municipality, China Not yet recruiting
Study contacts
- Study coordinator: Tao Liu, Master
- Email: liutao@neuracle.cn
- Phone: 021-58086056
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Portable control systems to operate a hand motor neuroprosthesis for people with tetraplegia
The study will test whether several fully portable, non‑invasive control methods (for example shoulder‑motion IMUs, surface EMG, touch/contact sensors, and voice) let adults with tetraplegia reliably control a hand motor neuroprosthesis.
-
Improving hand function in cervical spinal cord injury with nerve transfers and electrical stimulation
This study is testing if using electrical stimulation during and after nerve surgery can help people with cervical spinal cord injuries regain hand function and feel less pain.
-
Using a brain-computer interface to help people with tetraplegia communicate
This study is testing a new brain-computer interface to help people with tetraplegia communicate more easily using a tablet.
-
Nerve transfer surgery to enhance function in high tetraplegia
This study is testing if nerve transfer surgery can help people with high spinal cord injuries improve their arm function and quality of life.
-
Using a brain-computer interface to help people with speech difficulties communicate
This study is testing a brain-computer interface to help people who can't speak due to conditions like ALS communicate by turning their thoughts into speech.
-
MindEx multifocal cognitive brain‑machine interface for people with severe paralysis
This trial will test the MindEx system, which uses four tiny implanted brain chips to let people with severe paralysis control a computer or tablet with their thoughts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.